BioM's articles and press releases about the Bavarian biotechnology sector

m⁴ Seminar - new dates

The Mu­nich sem­in­ar series about per­son­al­ized medi­cine is con­tin­ued on Feb 21st and Mar 12th, 2013

New EU-Project in integrative omics-data-analysis: STATegra

Bio­max (Martin­sried) and Lud­wig-Max­imili­ans University (LMU) are part­ners.

Roche to invest 240 million Swiss francs in diagnostics production in Germany

The new Pen­zberg pro­duc­tion fa­cil­ity will help meet rising de­mand for dia­gnost­ic products and adds to Roche Group’s largest European…

Genomatix and CeGAT are among the 3 finalists of the Clarity competition

Full gen­ome se­quen­cing helps with the dia­gnos­is of dif­fi­cult cases

Freising-based XL-protein and Wacker annouce long-term cooperation

Pro­long­a­tion of the plasma half life of bio­lo­gics

Genesis Life Science and Healthcare Networking Conference

40 % dis­count for the BioM Net­zwerk for the con­fer­ence and part­ner­ing event in Lon­don

New agents for cancer immunotherapy: 4SC m⁴ receives grant

TLR7/TLR9 ag­on­ists will be de­veloped in co­oper­a­tion with the LMU uni­ver­sity hos­pit­al

Pieris AG in Freising receives first milestone in collaboration with Daiichi Sankyo

 Pier­is AG an­nounced today the achieve­ment of the first fin­an­cial mile­stone in its dis­cov­ery and de­vel­op­ment col­lab­or­a­tion…

GeneWake: Innovative diagnostics enables improved individual treatment of colon cancer

The pro­ject “In­nov­at­ive his­to­lo­gic­al de­tec­tion of muta­tions in KRAS, BRAF and PIK3CA for per­son­al­ized treat­ment of colorectal…

Digital is the future of pathology

Defini­ens com­pletes private fin­an­cing round with EUR 10 mil­lion